Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daptomycin/pharmacology"'
Autor:
Romain Garreau, Damien Montange, Antoine Grillon, François Jehl, Tristan Ferry, Laurent Bourguignon, Sylvain Goutelle
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 2022, 61 (10), pp.1443-1456. ⟨10.1007/s40262-022-01168-5⟩
Clinical Pharmacokinetics, 2022, 61 (10), pp.1443-1456. ⟨10.1007/s40262-022-01168-5⟩
International audience; Background and objective: Daptomycin has been recommended in the treatment of bone and joint infection. Previous work showed that the approved dosage of daptomycin may be insufficient to achieve optimal exposure in patients wi
Autor:
Andreas Otto, Kathrin Gries, D. S. Orlov, Hans-Georg Sahl, O. V. Shamova, Vladimir V. Zarubaev, Xinwei Sher, Patrice Francois, Fabian Grein, Myriam Girard, Anna Müller, Tanja Schneider, Dörte Becher, Terry Roemer
Publikováno v:
International Journal of Medical Microbiology, Vol. 308, No 3 (2018) pp. 335-348
The first-in-class lipopeptide antibiotic daptomycin (DAP) is highly active against Gram-positive pathogens including s-lactam and glycopeptide resistant strains. Its molecular mode of action remains enigmatic, since a defined target has not been ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5395f18e1a9948f658d1e5bde3fefb
https://archive-ouverte.unige.ch/unige:127898
https://archive-ouverte.unige.ch/unige:127898
Publikováno v:
Journal of Infectious Diseases
The Journal of Infectious Diseases, Vol. 206, No 8 (2012) pp. 1153-6
The Journal of Infectious Diseases, Vol. 206, No 8 (2012) pp. 1153-6
Comment on Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients. [J Infect Dis. 2012]
Autor:
Philippe Moreillon, José M. Entenza, Reno Frei, Christiane Rosin, Maja Weisser, Christine Bernsmeier, Ursula Flückiger
Publikováno v:
Swiss medical weekly, vol. 142, pp. w13603
We report a case series of 11 patients with severe E. faecium infections treated with daptomycin. All strains were resistant to ampicillin (MIC >8 mg/l), but susceptible to vancomycin. Seven out of 11 strains were also highly resistant to gentamicin
Autor:
Jacques Schrenzel, Patrice Francois, Richard A. Proctor, Sébastien Herzig, Alexander Scherl, Michael R. Yeaman, Ali R. Vaezzadeh, Myriam Girard, George Sakoulas, Adrien Nicolas Fischer, Arnold S. Bayer, Soo-Jin Yang, Ludwig Stenz
Publikováno v:
Journal of Antimicrobial Chemotherapy, Vol. 66, No 8 (2011) pp. 1696-711
Objectives The development of daptomycin resistance in Staphylococcus aureus is associated with clinical treatment failures. The mechanism(s) of such resistance have not been clearly defined. Methods We studied an isogenic daptomycin-susceptible (DAP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5c1906ef5316a1bd00f91194f2e601
https://archive-ouverte.unige.ch/unige:23524
https://archive-ouverte.unige.ch/unige:23524
Autor:
Patrice Francois, Yan Q. Xiong, Jacques Schrenzel, Arnold S. Bayer, Soo-Jin Yang, Andreas Peschel, Paul M. Dunman
Publikováno v:
Antimicrobial Agents and Chemotherapy, Vol. 53, No 6 (2009) pp. 2636-2637
We used a well-characterized isogenic set of clinical bloodstream Staphylococcus aureus strains to study (i) regulation of mprF -mediated phosphatidylglycerol lysinylation in the contexts of in vitro daptomycin (DAP) nonsuceptibility and (ii) the rol